These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21178622)

  • 61. Gastric emptying and prokinetics.
    Hegde R
    Intensive Care Med; 1997 Aug; 23(8):928. PubMed ID: 9310822
    [No Abstract]   [Full Text] [Related]  

  • 62. A pioneering study: oral clarithromycin treatment for feeding intolerance in very low birth weight preterm infants.
    Sancak S; Gursoy T; Tuten A; Arman D; Karatekin G; Ovali F
    J Matern Fetal Neonatal Med; 2018 Apr; 31(8):988-992. PubMed ID: 28279123
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Access options for withdrawn motility-modifying agents.
    Jones MP
    Am J Gastroenterol; 2002 Sep; 97(9):2184-8. PubMed ID: 12358230
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Cisapride and other prokinetic agents in the treatment of gastroenterological diseases].
    Ryss ES; Fishzon-Ryss IuI
    Ter Arkh; 1995; 67(2):58-61. PubMed ID: 7725263
    [No Abstract]   [Full Text] [Related]  

  • 65. Are the "good old" antibiotics still appropriate for early-onset neonatal sepsis? A 10 year survey.
    Maayan-Metzger A; Barzilai A; Keller N; Kuint J
    Isr Med Assoc J; 2009 Mar; 11(3):138-42. PubMed ID: 19544701
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Erythromycin and gastroduodenal contractile activity.
    Orenstein SR
    Curr Gastroenterol Rep; 2002 Jun; 4(3):227-8. PubMed ID: 12010623
    [No Abstract]   [Full Text] [Related]  

  • 67. Successful treatment with octreotide of spontaneous chylothorax in a premature infant.
    Coulter DM
    J Perinatol; 2004 Mar; 24(3):194-5. PubMed ID: 15044931
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [New findings on the biological activities of macrolides--antiviral effects of macrolide antibiotics].
    Yamaya M; Suzuki T; Asada M; Sasaki T; Nishimura H
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():679-82. PubMed ID: 17455704
    [No Abstract]   [Full Text] [Related]  

  • 69. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent.
    Weber FH; Richards RD; McCallum RW
    Am J Gastroenterol; 1993 Apr; 88(4):485-90. PubMed ID: 8470625
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prokinetic agents in the surgical patient.
    Thompson JS; Quigley EM
    Am J Surg; 1999 Jun; 177(6):508-14. PubMed ID: 10414704
    [No Abstract]   [Full Text] [Related]  

  • 71. Erythromycin for prokinesis: imprudent prescribing?
    Dall'Antonia M; Wilks M; Coen PG; Bragman S; Millar MR
    Crit Care; 2006 Feb; 10(1):112. PubMed ID: 16420656
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prokinetics-safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review.
    Bor S; Kalkan İH; Savarino E; Rao S; Tack J; Pasricha J; Cangemi D; Schol J; Karunaratne T; Ghisa M; Ahuja NK; Lacy B
    Neurogastroenterol Motil; 2024 May; 36(5):e14774. PubMed ID: 38462678
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.
    Nasr I; Rao SS; Attaluri A; Hashmi SM; Summers R
    Indian J Gastroenterol; 2009; 28(4):136-42. PubMed ID: 19937173
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cardiac toxicity of intravenous erythromycin lactobionate in preterm infants.
    Gouyon JB; Benoit A; Bétremieux P; Sandre D; Sgro C; Bavoux F; Beneton C; Badoual J
    Pediatr Infect Dis J; 1994 Sep; 13(9):840-1. PubMed ID: 7808866
    [No Abstract]   [Full Text] [Related]  

  • 75. Pathophysiology and Treatment of Gastrointestinal Motility Disorders in the Acutely Ill.
    Deane AM; Chapman MJ; Reintam Blaser A; McClave SA; Emmanuel A
    Nutr Clin Pract; 2019 Feb; 34(1):23-36. PubMed ID: 30294835
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ecthyma gangrenosum in preterm neonate.
    Srinivasan R; Arshid M; Platt MP
    Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F298. PubMed ID: 21402577
    [No Abstract]   [Full Text] [Related]  

  • 77. Upper gastrointestinal promotility drugs: not all uniform?
    Brun R; Kuo B
    Indian J Gastroenterol; 2009; 28(4):123-5. PubMed ID: 19937420
    [No Abstract]   [Full Text] [Related]  

  • 78. [The pharmacological basis of the treatment of disorders of gastrointestinal motility].
    Vantrappen G; Hellemans J; Janssens J
    Acta Gastroenterol Belg; 1967 Oct; 30(10):646-58. PubMed ID: 5594398
    [No Abstract]   [Full Text] [Related]  

  • 79. [The influence of macrolides on the motor function of the gastrointestinal duct].
    Saenko VF; Skomarovskiĭ AA; Polinkevich BS
    Klin Khir; 1998; (5):34-6. PubMed ID: 9787571
    [No Abstract]   [Full Text] [Related]  

  • 80. Erythromycin improves gastrointestinal motility in extremely low birthweight infants.
    Kubota M; Nakamura T; Motokura T; Mori S; Nishida A
    Acta Paediatr Jpn; 1994 Apr; 36(2):198-201. PubMed ID: 8203267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.